149 related articles for article (PubMed ID: 35973522)
41. Association of post-intervention pressure gradient with symptom-free at 6 months in idiopathic intracranial hypertension with venous sinus stenosis treated by stenting.
Wang S; Tong X; Li X; Liu L; Liu Z; Mo D; Wang Y
Interv Neuroradiol; 2023 Aug; 29(4):413-418. PubMed ID: 35469507
[TBL] [Abstract][Full Text] [Related]
42. Neuro-ophthalmological evaluation including optical coherence tomography surrounding venous sinus stenting in idiopathic intracranial hypertension with papilledema: a case series.
Hendrix P; Whiting CJ; Griessenauer CJ; Bohan C; Schirmer CM; Goren O
Neurosurg Rev; 2022 Jun; 45(3):2239-2247. PubMed ID: 35067804
[TBL] [Abstract][Full Text] [Related]
43. Endovascular stenting for idiopathic intracranial hypertension with venous sinus stenosis.
Liu X; Di H; Wang J; Cao X; Du Z; Zhang R; Yu S; Li B
Brain Behav; 2019 May; 9(5):e01279. PubMed ID: 30950244
[TBL] [Abstract][Full Text] [Related]
44. Cerebral venous sinus system and stenting in pseudotumor cerebri.
Dykhuizen MJ; Hall J
Curr Opin Ophthalmol; 2011 Nov; 22(6):458-62. PubMed ID: 21986881
[TBL] [Abstract][Full Text] [Related]
45. A case series of dural venous sinus stenting in idiopathic intracranial hypertension: association of outcomes with optical coherence tomography.
Smith KA; Peterson JC; Arnold PM; Camarata PJ; Whittaker TJ; Abraham MG
Int J Neurosci; 2017 Feb; 127(2):145-153. PubMed ID: 26863329
[TBL] [Abstract][Full Text] [Related]
46. Fifty shades of gradients: does the pressure gradient in venous sinus stenting for idiopathic intracranial hypertension matter? A systematic review.
McDougall CM; Ban VS; Beecher J; Pride L; Welch BG
J Neurosurg; 2018 Mar; 130(3):999-1005. PubMed ID: 29498569
[TBL] [Abstract][Full Text] [Related]
47. Endovascular Treatment for Venous Sinus Stenosis in Idiopathic Intracranial Hypertension: An Observational Study of Clinical Indications, Surgical Technique, and Long-Term Outcomes.
Shields LBE; Shields CB; Yao TL; Plato BM; Zhang YP; Dashti SR
World Neurosurg; 2019 Jan; 121():e165-e171. PubMed ID: 30248468
[TBL] [Abstract][Full Text] [Related]
48. Major complications of dural venous sinus stenting for idiopathic intracranial hypertension: case series and management considerations.
Townsend RK; Jost A; Amans MR; Hui F; Bender MT; Satti SR; Maurer R; Liu K; Brinjikji W; Fargen KM
J Neurointerv Surg; 2022 Jan; 14(1):. PubMed ID: 33911014
[TBL] [Abstract][Full Text] [Related]
49. Visual outcomes and headache following interventions for idiopathic intracranial hypertension.
Lai LT; Danesh-Meyer HV; Kaye AH
J Clin Neurosci; 2014 Oct; 21(10):1670-8. PubMed ID: 24974193
[TBL] [Abstract][Full Text] [Related]
50. Complete ophthalmoplegia secondary to idiopathic intracranial hypertension managed successfully with dural sinus stenting: A case and systematic review.
Mathkour M; Scullen T; Kilgore MD; Gouveia EE; Chu J; Abou-Al-Shaar H; Tubbs RS; Khan F; Bui CJ
Clin Neurol Neurosurg; 2021 Oct; 209():106910. PubMed ID: 34560385
[TBL] [Abstract][Full Text] [Related]
51. [Treatment of idiopathic intracranial hypertension by endovascular improvement of venous drainage of the brain].
Aguilar-Pérez M; Henkes H
Ophthalmologe; 2015 Oct; 112(10):821-7. PubMed ID: 26400795
[TBL] [Abstract][Full Text] [Related]
52. Should topiramate be initial therapy in the management of idiopathic intracranial hypertension?: A literature review.
Goyal A; Zarroli K
Medicine (Baltimore); 2023 Oct; 102(42):e35545. PubMed ID: 37861536
[TBL] [Abstract][Full Text] [Related]
53. Future Directions and Innovations in Venous Sinus Stenting.
Pandey A; Schreiber C; Garton ALA; Jung B; Goldberg JL; Kocharian G; Carnevale JA; Boddu SR
World Neurosurg; 2024 Apr; 184():387-394. PubMed ID: 38590072
[TBL] [Abstract][Full Text] [Related]
54. Emergent cerebral venous stenting: A valid treatment option for fulminant idiopathic intracranial hypertension.
Horev A; Ben-Arie G; Walter E; Tsumi E; Regev T; Aloni E; Biederko R; Zlotnik Y; Lebowitz Z; Shelef I; Honig A
J Neurol Sci; 2023 Sep; 452():120761. PubMed ID: 37572407
[TBL] [Abstract][Full Text] [Related]
55. Pulsatile versus non-pulsatile tinnitus in idiopathic intracranial hypertension.
Funnell JP; Craven CL; Thompson SD; D'Antona L; Chari A; Thorne L; Watkins LD; Toma AK
Acta Neurochir (Wien); 2018 Oct; 160(10):2025-2029. PubMed ID: 30014363
[TBL] [Abstract][Full Text] [Related]
56. Intracranial Venous Sinus Stenting: A Review of Idiopathic Intracranial Hypertension and Expanding Indications.
Daggubati LC; Liu KC
Cureus; 2019 Feb; 11(2):e4008. PubMed ID: 31001462
[TBL] [Abstract][Full Text] [Related]
57. Impaired drainage of vein of Labbé following venous sinus stenting for idiopathic intracranial hypertension.
Boddu SR; Gobin YP; Dinkin M; Oliveira C; Patsalides A
J Neurointerv Surg; 2019 Mar; 11(3):300-306. PubMed ID: 30219791
[TBL] [Abstract][Full Text] [Related]
58. Intracranial Access: Dural Venous Sinus Stenting: 2-Dimensional Operative Video.
Domingo RA; Ravindran K; Kulakova K; Tawk RG;
Oper Neurosurg (Hagerstown); 2021 Jul; 21(2):E113-E114. PubMed ID: 33891009
[TBL] [Abstract][Full Text] [Related]
59. Venous sinus stenting for idiopathic intracranial hypertension: a systematic review and meta-analysis.
Nicholson P; Brinjikji W; Radovanovic I; Hilditch CA; Tsang ACO; Krings T; Mendes Pereira V; Lenck S
J Neurointerv Surg; 2019 Apr; 11(4):380-385. PubMed ID: 30166333
[TBL] [Abstract][Full Text] [Related]
60. Association of spontaneous cerebrospinal fluid rhinorrhea with transverse venous sinus stenosis: a retrospective matched case-control study.
Bedarida V; Labeyrie MA; Eliezer M; Saint-Maurice JP; Jourdaine C; Gargalas S; Herman P; Houdart E; Verillaud B
Int Forum Allergy Rhinol; 2020 Dec; 10(12):1295-1299. PubMed ID: 32702193
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
